Home  >  News
Eppen_Multi_Oct24
you can get e-magazine links on WhatsApp. Click here
News
  Bayer submits marketing authorization application to EMA for elinzanetant to treat moderate to severe vasomotor symptoms,   October 16, 2024
  UK’s life sciences sector to receive a £279 million boost to tackle significant health challenges,   October 16, 2024
  Dharmendra Pradhan announces 3 CoEs in AI in healthcare, agriculture and sustainable cities,   October 16, 2024
  Lilly announces positive results from phase 3 study of mirikizumab compared to ustekinumab for Crohn's disease,   October 15, 2024
  Bausch + Lomb receives US FDA approval for enVista Envy full range of vision intraocular lens,   October 15, 2024
  MedGenome marks 10 years of genomics in India, works to further its research and diagnostics in disease prevention,   October 15, 2024
  Ardena inks agreement to acquire Catalent’s state-of-the-art facility in Somerset, New Jersey,   October 15, 2024
  Ampath collaborates with Innocent Hearts Hospital to expand diagnostic services in Jalandhar,   October 15, 2024
  HealthPlix gets HIPAA certification, reinforcing its efforts in patient data privacy and security,   October 15, 2024
  C-CAMP with ICARS to support innovative solutions to address the challenge of AMR across the One Health domain,   October 15, 2024
  Lundbeck to buy clinical-stage biopharma company, Longboard Pharmaceuticals for USD 2.6 billion,   October 15, 2024
  Dizal gets China NMPA breakthrough therapy designation for sunvozertinib to treat NSCLC with EGFR exon 20 insertion mutations,   October 15, 2024
  Exelixis, Merck enter clinical development collaboration to evaluate zanzalintinib in combo with Keytruda in HNSCC and in combo with Welireg in RCC,   October 15, 2024
  Lupin introduces generic Pred Forte in United States,   October 15, 2024
  US FDA approves UCB’s 320 mg single-injection device presentations of Bimzelx,   October 15, 2024
  USV introduces OnArni for management of heart failure,   October 15, 2024
  Majority of children with SMA treated with Roche’s Evrysdi are able to sit, stand and walk independently, two-year data demonstrate,   October 15, 2024
  Waters new bioseparations tools improve development of RNA-based vaccines and therapies using LC-MS analysis,   October 15, 2024
  GSK announces positive phase III results from ANCHOR trials for depemokimab in chronic rhinosinusitis with nasal polyps,   October 15, 2024
  China NMPA grants conditional approval to AstraZeneca & Daiichi Sankyo’s Enhertu as first HER2-directed therapy for patients with HER2-mutant metastatic NSCLC,   October 15, 2024

  • Results Found: 115175
  • 1
    •  
  • 2
    •  
  • 3
    •  
  • 4
    •  
  • 5
    •  
  • Go to
  • Total Number of Pages: 5759
 Back
 
avians24_PB
BTS_2024
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram